Sign in
Taking people in United StatesNo phase

How exercise changes blood proteins in adults with restless legs syndrome

Tests how exercise changes blood proteins in adults with restless legs syndrome.

Key facts

Who runs it
Stanford University
Where
Stanford, United StatesSee the site
Trial code
Registry title
Blood Changes After Exercise in Restless Legs Syndrome
Status
Recruiting
People taking part
30 people, planned
Started
21 Oct 2024
Expected to end
Dec 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • 12-Week RLS Exercise Program
Record updated
27 November 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with moderate-to-severe restless legs syndrome (RLS) that is not treated, who are not physically active. It studies how exercise changes proteins in the blood.

Age
18 years or older
Sex
All sexes can join
Disease stage
Moderate-to-severe RLS (IRLS score>15), currently untreated.
Earlier treatment
RLS must be currently untreated.

Main reasons for not taking part

  • A condition that can look like RLS or cause it, such as iron deficiency anemia, radiculopathy, peripheral edema, peripheral neuropathy or diabetes
  • Moderate or high risk from hard or maximal exercise
  • Regular activity (30 minutes per day) on more than 2 days a week in the past six months
  • Needing a cane, walker or wheelchair to get around

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • age 18 years or older
  • diagnosis of RLS
  • presence of moderate-to-severe RLS (IRLS score>15)
  • currently untreated RLS
  • being non-active defined as not engaging in regular activity (30 minutes accumulated per day) on more than 2 days of the week during the previous six months
  • ability to walk without assistance (does not use a cane/walker/wheelchair for mobility
  • willing to complete outcome measures and complete the exercise program

Who cannot take part

  • present with a condition that can mimic RLS or cause secondary RLS (e.g., iron deficiency anemia, radiculopathy, peripheral edema, peripheral neuropathy, diabetes)
  • are at moderate or high risk for undertaking strenuous or maximal exercise

Where in United States

  • Stanford UniversityStanford, United StatesContact: Katie Cederberg, PhDTaking people

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn how exercise changes molecules in the blood in people with restless legs syndrome (RLS) to better understand the cause(s) of RLS. The main questions the investigators aim to answer are:

Read full original descriptionShow less

How does long-term exercise change proteins in the blood?

How does a single exercise session change proteins in the blood?

The investigators will compare long-term exercise to no exercise to see if the changes in proteins are specific to exercise.

Participants will complete an exercise test and provide blood samples before and after the exercise test. Participants will be randomized (like the flip of a coin) in to either the exercise or no-exercise group for 12 weeks and then complete the exercise test and blood samples again at the end.

The 2 groups in the trial

  • ExerciseTreatment being tested

    Participants will complete a 12-week, RLS specific exercise program including strength training, cardiovascular exercise, and stretching.

    Treatment: 12-Week RLS Exercise Program

  • Non-ExerciseNo study treatment, for comparison

    Participants will have no intervention or interaction for 12 weeks.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Proteomic Response to Exercise in Adults With Restless Legs Syndrome
Plain-language title
How exercise changes blood proteins in adults with restless legs syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
27 November 2024